Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pain in Parkinson's Disease.

Jacob I. Sage1

  • 1Department of Neurology, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, 97 Patterson Street, New Brunswick, NJ 08901, USA. sage@umdnj.edu

Current Treatment Options in Neurology
|March 27, 2004
PubMed
Summary

Pain in Parkinson's disease (PD) can be categorized by levodopa levels. Treatment strategies aim to optimize dopaminergic stimulation for low DOPA pain, reduce dopaminergic agents for high DOPA pain, and address other causes for nonspecific pain.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Visual Impairment and Driving in Older Adults: A Narrative Review.

Current treatment options in neurology·2026
Same journal

Non-Cognitive Symptoms in Alzheimer's Disease and Their Likely Impact on Patient Outcomes. A Scoping Review.

Current treatment options in neurology·2026
Same journal

Update on the Treatment of Autonomic Disorders.

Current treatment options in neurology·2025
Same journal

Primary Progressive Aphasia Treatment: Current Treatment Options in Neurology Article Topic: Management of Primary Progressive Aphasia.

Current treatment options in neurology·2025
Same journal

Emerging Principles for Treating Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD).

Current treatment options in neurology·2025
Same journal

Diagnosis and Management of Progressive Corticobasal Syndrome.

Current treatment options in neurology·2025

Area of Science:

  • Neurology
  • Pain Management
  • Parkinson's Disease Therapeutics

Background:

  • Nearly 50% of Parkinson's disease (PD) patients experience pain, which can be more debilitating than motor symptoms.
  • Pain in PD can be linked to dopaminergic medication levels or other underlying conditions.
  • Effective pain management is crucial for improving the quality of life in PD patients.

Purpose of the Study:

  • To categorize PD-related pain syndromes based on their relationship with dopaminergic therapy.
  • To outline appropriate treatment strategies for each identified pain category.
  • To provide guidance for optimizing pain management in Parkinson's disease.

Main Methods:

  • Categorization of pain into three types: low DOPA (inadequate stimulation), high DOPA (peak stimulation), and non-dopaminergic related.
  • Review of treatment strategies, including medication adjustments (dopamine agonists, COMT inhibitors, levodopa), and advanced interventions (deep brain stimulation, duodenal infusion).
  • Consideration of amantadine for chorea-related pain and treatment of underlying PD for early-stage nonspecific pain.

Main Results:

  • Low DOPA pain is managed by enhancing continuous dopaminergic stimulation.
  • High DOPA pain is treated by reducing dopaminergic medication dosage.
  • Nonspecific pain requires addressing underlying PD or using analgesics, though efficacy can be anecdotal.

Conclusions:

  • Tailoring treatment to specific pain categories (low DOPA, high DOPA, nonspecific) is essential for effective pain management in Parkinson's disease.
  • Optimizing dopaminergic therapy and considering advanced interventions can alleviate medication-related pain.
  • Further research may be needed to establish evidence-based treatments for nonspecific PD pain.

Related Experiment Videos